Felix
Ernst & Young
A Headline Drug Deal Is Only the Tip of a More Complicated Drive for Profit
by Shine
July 29, 2026Felix
Ernst & Young
Share Article:
Loading video...
#Felix#Ernst & Young
Share Article:
In Case You Missed It...
Latest Articles

FEATURED
[Biopharma]
AI-Driven Drug Research Hastens Discovery, But Can It Lead to Clinical Success?
@ Tan Weiyun
Jul 18, 2026
[BIOPHARMA]
AI-Driven Drug Research Hastens Discovery, But Can It Lead to Clinical Success?
@ Tan Weiyun
Jul 18, 2026

[Biopharma]
China Drugmakers Climb the Value Chain as a National 'Pillar Industry'
China's biotech research has attracted global attention, with licensing agreements turning to more collaborative partnerships.

[Industry]
China Ends Year of Strength, Resilience and Global Influence
As the 21st century enters its second quarter, China is poised for a greater role in advancing science and technology, and a bigger presence on the world stage.

[Inside CIIE]
Generative AI Leads the Change in Medical Device Market
The medical device industry is shifting from volume to value, from selling equipment to providing intelligence. This trend centers on AI, especially generative AI.
![[The List] China's Hope & Sesame Wins the No. 1 Bar in Asia 2026](https://obj.shine.cn/files/2026/07/29/681a5953-b4f4-45f0-b43d-5921acebad36_0.png)

![[Quick News] District in Shanghai is Now Offering 5-Year Visas](https://obj.shine.cn/files/2026/07/24/ac0e57c9-6881-4c4f-839d-6e999d81c5a2_0.jpg)

